M Findlay
Impact in
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment
-
- Gastric Cancer Management and Outcomes
- Metastasis and carcinoma case studies
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 5
- Colorectal Cancer Treatments and Studies 5
- Cancer Treatment and Pharmacology 3
- Cancer Diagnosis and Treatment 1
- Colorectal Cancer Surgical Treatments 1
-
- Gastric Cancer Management and Outcomes 2
- Co-authors
- David Cunningham (3 shared papers)Tamas Hickish (2 shared papers)A. Norman (2 shared papers)Andrew Webb (2 shared papers)J.H. Scarffe (1 shared paper)MC Nicolson (1 shared paper)Janine Mansi (1 shared paper)Peter Harper (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Human Mutation (1 paper)Annals of Oncology (1 paper)Lung Cancer (1 paper)Breast Cancer Research and Treatment (1 paper)
- Partner nations
- United KingdomSouth KoreaItaly
In The Last Decade
M Findlay
8 papers receiving 867 citations
M Findlay's Hit Papers
Peers
Comparison fields: 5 of 57
- Gastroenterology 167
- Pulmonary and Respiratory Medicine 659
- Oncology 511
- Surgery 361
- Pathology and Forensic Medicine 69
Countries citing papers authored by M Findlay
This map shows the geographic impact of M Findlay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Findlay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Findlay more than expected).
Fields of papers citing papers by M Findlay
This network shows the impact of papers produced by M Findlay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Findlay. The network helps show where M Findlay may publish in the future.
Co-authors
The 25 scholars most cited alongside M Findlay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. Hit paper breakdown → | 1997 | 691 |
| 2 | 1995 | 69 | |
| 3 | 2002 | 56 | |
| 4 | 1996 | 47 | |
| 5 | 1997 | 13 | |
| 6 | Survival benefit with Xeloda (capecitabine)/docetaxel vs docetaxel: analysis of post-study therapy. | 2001 | 12 |
| 7 | 2000 | 1 | |
| 8 | 2008 | 1 |
About M Findlay
M Findlay is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Surgery and Molecular Biology, having authored 8 papers that have together received 890 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (5 papers), Cancer Treatment and Pharmacology (3 papers), Genetic factors in colorectal cancer (2 papers), Gastric Cancer Management and Outcomes (2 papers), Cancer-related gene regulation (1 paper), Cancer Diagnosis and Treatment (1 paper), Colorectal Cancer Surgical Treatments (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Gastroenterology (167 citations), Pulmonary and Respiratory Medicine (659 citations), Oncology (511 citations), Surgery (361 citations) and Pathology and Forensic Medicine (69 citations). M Findlay has collaborated with scholars based in United Kingdom, South Korea and Italy. Frequent co-authors include David Cunningham, Tamas Hickish, A. Norman, Andrew Webb, J.H. Scarffe, MC Nicolson, Janine Mansi, Peter Harper, Matthew Watson and J. Oates. Their work appears in journals such as Journal of Clinical Oncology, Human Mutation, Annals of Oncology, Lung Cancer and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.